207 related articles for article (PubMed ID: 31498999)
1. Quantitative Drug Release Monitoring in Tumors of Living Subjects by Magnetic Particle Imaging Nanocomposite.
Zhu X; Li J; Peng P; Hosseini Nassab N; Smith BR
Nano Lett; 2019 Oct; 19(10):6725-6733. PubMed ID: 31498999
[No Abstract] [Full Text] [Related]
2. Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.
Akbarzadeh A; Mikaeili H; Zarghami N; Mohammad R; Barkhordari A; Davaran S
Int J Nanomedicine; 2012; 7():511-26. PubMed ID: 22334781
[TBL] [Abstract][Full Text] [Related]
3. Theranostic nanocarriers combining high drug loading and magnetic particle imaging.
Fuller EG; Scheutz GM; Jimenez A; Lewis P; Savliwala S; Liu S; Sumerlin BS; Rinaldi C
Int J Pharm; 2019 Dec; 572():118796. PubMed ID: 31678389
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging.
Zhu L; Wang D; Wei X; Zhu X; Li J; Tu C; Su Y; Wu J; Zhu B; Yan D
J Control Release; 2013 Aug; 169(3):228-38. PubMed ID: 23485450
[TBL] [Abstract][Full Text] [Related]
5. Design of hybrid protein-coated magnetic core-mesoporous silica shell nanocomposites for MRI and drug release assessed in a 3D tumor cell model.
Ménard M; Meyer F; Affolter-Zbaraszczuk C; Rabineau M; Adam A; Ramirez PD; Bégin-Colin S; Mertz D
Nanotechnology; 2019 Apr; 30(17):174001. PubMed ID: 30641488
[TBL] [Abstract][Full Text] [Related]
6. Side effects-avoided theranostics achieved by biodegradable magnetic silica-sealed mesoporous polymer-drug with ultralow leakage.
Li C; Wang Y; Du Y; Qian M; Jiang H; Wang J; Murthy N; Huang R
Biomaterials; 2018 Dec; 186():1-7. PubMed ID: 30273749
[TBL] [Abstract][Full Text] [Related]
7. The first visualization of chemotherapy-induced tumor apoptosis via magnetic particle imaging in a mouse model.
Liang X; Wang K; Du J; Tian J; Zhang H
Phys Med Biol; 2020 Sep; 65(19):195004. PubMed ID: 32764190
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
[TBL] [Abstract][Full Text] [Related]
9. MRI-visual order-disorder micellar nanostructures for smart cancer theranostics.
Patra HK; Ul Khaliq N; Romu T; Wiechec E; Borga M; Turner AP; Tiwari A
Adv Healthc Mater; 2014 Apr; 3(4):526-35. PubMed ID: 23983185
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Cross-linked Poly (N-isopropylacrylamide) Magnetic Nano Composite for Application in the Controlled Release of Doxorubicin.
Kaamyabi S; Badrian A; Akbarzadeh A
Pharm Nanotechnol; 2017; 5(1):67-75. PubMed ID: 28948911
[TBL] [Abstract][Full Text] [Related]
11. Thermoresponsive polymer gated and superparamagnetic nanoparticle embedded hollow mesoporous silica nanoparticles as smart multifunctional nanocarrier for targeted and controlled delivery of doxorubicin.
Asghar K; Qasim M; Dharmapuri G; Das D
Nanotechnology; 2020 Nov; 31(45):455604. PubMed ID: 32311684
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characteristics of Fe3O4 magnetic nanocomposites based on Poly(N-isopropylacrylamide) for anti-cancer drug delivery.
Davaran S; Alimirzalu S; Nejati-Koshki K; Nasrabadi HT; Akbarzadeh A; Khandaghi AA; Abbasian M; Alimohammadi S
Asian Pac J Cancer Prev; 2014; 15(1):49-54. PubMed ID: 24528080
[TBL] [Abstract][Full Text] [Related]
13. IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy.
Fu X; Wang X; Zhou S; Zhang Y
Int J Nanomedicine; 2017; 12():3751-3766. PubMed ID: 28553112
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterisation of a pH-sensitive magnetic nanocomposite for controlled delivery of doxorubicin.
Xu SS; Wu J; Jiang W
J Microencapsul; 2015; 32(6):533-7. PubMed ID: 26289219
[TBL] [Abstract][Full Text] [Related]
15. MR-labelled liposomes and focused ultrasound for spatiotemporally controlled drug release in triple negative breast cancers in mice.
Amrahli M; Centelles M; Cressey P; Prusevicius M; Gedroyc W; Xu XY; So PW; Wright M; Thanou M
Nanotheranostics; 2021; 5(2):125-142. PubMed ID: 33457192
[No Abstract] [Full Text] [Related]
16. Co-delivery of doxorubicin and oleanolic acid by triple-sensitive nanocomposite based on chitosan for effective promoting tumor apoptosis.
Chen X; Niu S; Bremner DH; Zhang X; Zhang H; Zhang Y; Li S; Zhu LM
Carbohydr Polym; 2020 Nov; 247():116672. PubMed ID: 32829800
[TBL] [Abstract][Full Text] [Related]
17. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
[TBL] [Abstract][Full Text] [Related]
18. Dynamic in vivo imaging of dual-triggered microspheres for sustained release applications: synthesis, characterization and cytotoxicity study.
Efthimiadou EK; Tapeinos C; Chatzipavlidis A; Boukos N; Fragogeorgi E; Palamaris L; Loudos G; Kordas G
Int J Pharm; 2014 Jan; 461(1-2):54-63. PubMed ID: 24286923
[TBL] [Abstract][Full Text] [Related]
19. Magnetophoretic Delivery of a Tumor-Priming Agent for Chemotherapy of Metastatic Murine Breast Cancer.
Park J; Park J; Castanares MA; Collins DS; Yeo Y
Mol Pharm; 2019 May; 16(5):1864-1873. PubMed ID: 30916974
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Effect Evaluation of Magnetotherapy and a Cationic-Magnetic Nanocomposite Loaded with Doxorubicin for Targeted Drug Delivery to Breast Adenocarcinoma.
Naghaviyan A; Hashemi-Moghaddam H; Zavareh S; Ebrahimi Verkiani M; Meuller A
Mol Pharm; 2023 Jan; 20(1):101-117. PubMed ID: 36475680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
